Respiratory Muscle Weakness

Cross-source consensus on Respiratory Muscle Weakness from 1 sources and 5 claims.

1 sources · 5 claims

How it works

ICU-acquired respiratory muscle weakness is presented as a central driver of weaning failure. — Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial
The core problem in respiratory muscle weakness is a mismatch between respiratory muscle load and diminished capacity. — Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial
Respiratory muscle weakness in ventilated patients arises from both muscle atrophy and reduced calcium sensitivity of contraction. — Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial
Respiratory muscle weakness occurs frequently in patients ventilated for more than 24 hours by the time a weaning attempt is made. — Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial
Reduced calcium sensitivity lowers contractile efficiency and increases energy consumption and carbon dioxide production. — Weaning from invasive ventilation with levosimendan (WEANLESS): study protocol for a multicentre randomised clinical trial